chronic myelogenous leukemia

Showing NaN - NaN of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Chronic Myelogenous Leukemia Trial in Worldwide (Nilotinib followed by treatment-free)

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Nilotinib followed by treatment-free
  • Fort Myers, Florida
  • +113 more
Apr 25, 2022

Biology of Long-Term Late Effects Following Hematopoietic Cell

Active, not recruiting
  • Acute Lymphoblastic Leukemia/Lymphoma
  • +4 more
    • Scottsdale, Arizona
    • +31 more
    Mar 8, 2022

    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Australia, Canada, United States

    Completed
    • Acute Myelogenous Leukemia
    • +4 more
    • Single Umbilical Cord Blood Unit Transplant
    • +6 more
    • Birmingham, Alabama
    • +37 more
    Oct 13, 2021

    Chronic Myelogenous Leukemia, Hematologic Malignancies Trial in United States (Ponatinib)

    Completed
    • Chronic Myelogenous Leukemia
    • Hematologic Malignancies
    • San Francisco, California
    • +4 more
    May 15, 2018

    Chronic Myelogenous Leukemia Trial in Worldwide (imatinib mesilate, interferon-alpha (INF-a), cytarabine (ARA-C))

    Completed
    • Chronic Myelogenous Leukemia
    • imatinib mesilate
    • +2 more
    • Birmingham, Alabama
    • +162 more
    Aug 7, 2013

    Chronic Myelogenous Leukemia Trial in Worldwide (Dasatinib)

    Completed
    • Chronic Myelogenous Leukemia
    • Birmingham, Alabama
    • +69 more
    Apr 13, 2011